Inventor · disambiguated record
Janine Bilsborough
Also filed as: BILSBOROUGH JANINE · BILSBOROUGH JANINE M
60 granted patents·55 pending applications·1,296 citations·filing 2002–2025
99Inventor score
Files withZYMOGENETICS INC62CEDARS SINAI MEDICAL CENTER19PROMETHEUS BIOSCIENCES INC13GAO ZEREN3SIADAK ANTHONY W3
Top patents by PatentIndex Score
115 records- 0199US9878038B2Methods of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2017·Granted Jan 30, 2018·55 cites·4 claims
- 0299US9624296B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Apr 18, 2017·51 cites·6 claims
- 0399US7939068B2Antagonizing signal transduction in dorsal root ganglion cells in a subject with IL-31 antagonistsZYMOGENETICS INC·Filed 2009·Granted May 10, 2011·55 cites·28 claims
- 0499US7531637B2IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2006·Granted May 12, 2009·87 cites·54 claims
- 0599US7514077B2Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonistsZYMOGENETICS INC·Filed 2007·Granted Apr 7, 2009·65 cites·32 claims
- 0698US10434173B2Use of IL-31 monoclonal antibodies for treating pruritusZYMOGENETICS INC·Filed 2017·Granted Oct 8, 2019·49 cites·4 claims
- 0798US9011858B2Variable region sequences of IL-31 monoclonal antibodies and methods of useZYMOGENETICS INC·Filed 2013·Granted Apr 21, 2015·62 cites·9 claims
- 0898US8466262B2Variable region sequences of IL-31 monoclonal antibodies and methods of useSIADAK ANTHONY W·Filed 2007·Granted Jun 18, 2013·106 cites·9 claims
- 0998US8105590B2Methods of treating inflammation in neuronal tissueYAO YUE·Filed 2011·Granted Jan 31, 2012·49 cites·7 claims
- 1098US8017122B2Methods of using IL-31 monoclonal antibodies to reduce inflammationZYMOGENETICS INC·Filed 2009·Granted Sep 13, 2011·69 cites·18 claims
- 1198US7943132B2Methods of treating pain using antagonists of IL-31, IL-31RA and/or OSMRBZYMOGENETICS INC·Filed 2009·Granted May 17, 2011·40 cites·23 claims
- 1298US7638126B2Methods of treating pain and inflammation in neuronal tissue using antagonists of IL-31, IL31Ra and/or OSMRbZYMOGENETICS INC·Filed 2007·Granted Dec 29, 2009·60 cites·25 claims
- 1397US10322174B2Neutralizing anti-TL1A monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Jun 18, 2019·25 cites·7 claims
- 1497US9822177B2Method of reducing pruritus using IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2016·Granted Nov 21, 2017·14 cites·6 claims
- 1597US8637015B2Methods of antagonizing signal transduction in dorsal root ganglion cellsZYMOGENETICS INC·Filed 2013·Granted Jan 28, 2014·23 cites·13 claims
- 1697US8377438B2Methods of antagonizing signal transduction in spinal cord cellsZYMOGENETICS INC·Filed 2011·Granted Feb 19, 2013·32 cites·7 claims
- 1797US8105591B2Methods of antagonizing signal transduction in dorsal root ganglion cellsYAO YUE·Filed 2011·Granted Jan 31, 2012·39 cites·5 claims
- 1897US7723048B2Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonistsZYMOGENETICS INC·Filed 2008·Granted May 25, 2010·39 cites·4 claims
- 1996US9695238B2Screening method for inhibitors of binding of zBR7R1 to CD155ZYMOGENETICS INC·Filed 2016·Granted Jul 4, 2017·22 cites·14 claims
- 2096US8968732B2Methods of treating pain using an IL-31 monoclonal antibodyZYMOGENETICS INC·Filed 2013·Granted Mar 3, 2015·15 cites·13 claims
- 2196US8409571B2Methods of antagonizing signal transduction in spinal cord cellsYAO YUE·Filed 2011·Granted Apr 2, 2013·21 cites·5 claims
- 2296US7871618B2Methods of treating skin disorders using an IL-31RA antagonistZYMOGENETICS INC·Filed 2009·Granted Jan 18, 2011·23 cites·24 claims
- 2395US11440954B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·7 cites·20 claims
- 2495US11434296B2Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A functionCEDARS SINAI MEDICAL CENTER·Filed 2020·Granted Sep 6, 2022·5 cites·16 claims
- 2595US11292848B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Apr 5, 2022·14 cites·20 claims
- 2695US9994637B2Method of treating CD155 expressing cancersZYMOGENETICS INC·Filed 2017·Granted Jun 12, 2018·11 cites·10 claims
- 2795US8685395B2Methods of antagonizing signal transduction in dorsal root ganglion cellsZYMOGENETICS INC·Filed 2013·Granted Apr 1, 2014·15 cites·4 claims
- 2895US8568723B2Method of reducing pruritis using IL-31 monoclonal antibodiesSIADAK ANTHONY W·Filed 2011·Granted Oct 29, 2013·26 cites·8 claims
- 2994US11136386B2Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)PROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Oct 5, 2021·12 cites·53 claims
- 3094US9683037B2Method of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2016·Granted Jun 20, 2017·10 cites·14 claims
- 3194US9156909B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2013·Granted Oct 13, 2015·16 cites·9 claims
- 3294US8974783B2Methods of treating pain using an IL-31Ra or OSMR-b antagonistZYMOGENETICS INC·Filed 2014·Granted Mar 10, 2015·11 cites·7 claims
- 3394US8388964B2Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cellsLEUNG DONALD Y M·Filed 2011·Granted Mar 5, 2013·26 cites·6 claims
- 3493US9512219B2IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Dec 6, 2016·8 cites·7 claims
- 3593US7799323B2Methods of using IL-31 to treat airway hyper-responsiveness and asthmaZYMOGENETICS INC·Filed 2008·Granted Sep 21, 2010·30 cites·12 claims
- 3692US11999789B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·7 claims
- 3792US10633449B2Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2014·Granted Apr 28, 2020·12 cites·17 claims
- 3892US10273297B2Use of IL-31 monoclonal antibodies for reducing pruritusZYMOGENETICS INC·Filed 2017·Granted Apr 30, 2019·5 cites·6 claims
- 3992US8435745B2Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cellsBILSBOROUGH JANINE M·Filed 2010·Granted May 7, 2013·16 cites·5 claims
- 4092US7910540B2Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted Mar 22, 2011·17 cites·6 claims
- 4190US9334321B2Methods of treating neuronal inflammation using an IL-31 monoclonal antibodyZYMOGENETICS INC·Filed 2015·Granted May 10, 2016·4 cites·1 claims
- 4289US10259868B2Methods of treating atopic dermatitis with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2017·Granted Apr 16, 2019·4 cites·8 claims
- 4389US8268773B2Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonistPRESNELL SCOTT R·Filed 2011·Granted Sep 18, 2012·12 cites·6 claims
- 4488US9334322B2Methods of antagonizing signal transduction in spinal cord cells using an IL-31Ra or OSMR-b antagonistZYMOGENETICS INC·Filed 2015·Granted May 10, 2016·3 cites·4 claims
- 4587US12215147B2Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibodyPROMETHEUS BIOSCIENCES INC·Filed 2021·Granted Feb 4, 2025·1 cites·45 claims
- 4686US11186872B2Methods of diagnosing inflammatory bowel disease through RNASET2CEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Nov 30, 2021·8 cites·18 claims
- 4786US8926957B2Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cellsZYMOGENETICS INC·Filed 2013·Granted Jan 6, 2015·4 cites·6 claims
- 4885US2024368263A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 4984US9139651B2Methods of treatment using IL-31RABILSBOROUGH JANINE·Filed 2011·Granted Sep 22, 2015·6 cites·3 claims
- 5084US8029775B2Methods of determining dose of IL-31 agonist to treat pulmonary inflammationZYMOGENETICS INC·Filed 2010·Granted Oct 4, 2011·8 cites·12 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →